Keywords: atrix, submits, atridox, dossier, mca, laboratories, filed

Atrix Submits Atridox Dossier To MCA

Article | 16 October 1997

Print This

- Atrix Laboratories has filed for approval to market Atridox(doxycycline), for the treatment of periodontal disease, with the UK's Medicines ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in